Gamete Treatment to Correct Fertilization Failure
Part of paid clinical trials in New York, New York.
- Sponsor
- Weill Medical College of Cornell University
- Study ID
- NCT01944332
- Status
- Recruiting
Conditions
- Infertility
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - 89 Years
- Healthy Volunteers
- Not accepted
Interventions
- gamete treatment — PROCEDUREPatient specimen will be selected through a synthetic, sterile, single-use, culture-tested mesh. The specimen will then be placed in a 37°C environment. After 30 minutes, the selected portion is retrieved from the other side of the mesh. The spermatozoa will be prepared in the standard fashion and utilized for injection or intrauterine insemination after exposure to a membrane permeabilizing agent. Human recombinant PLC-zeta will also be used if the spermatozoa have been confirmed to be PLC-zeta deficient. The injected oocytes will then be exposed to activating agents for the purpose of inducing embryo development. The oocyte activating agent is calcium ionophore and for sperm membrane permeabilization to assist in sperm DNA decondensation is streptolysin O (SLO).
Study Details
In this proposed research study, the investigators plan to assess the efficacy of gametes' (egg and sperm) treatment on fertilization as well as pre- and post-implantation embryo development.
Key Dates
- Start date
- Sep 30, 2007
- Status verified
- Dec 2025
- Primary completion
- Jun 30, 2027
- Completion
- Nov 30, 2027
Study Design
- Enrollment
- 1,200 participants (estimated)
- Allocation
- NA
- Intervention model
- SEQUENTIAL
- Primary purpose
- TREATMENT
Arms
- Experimental: gamete treatment- oocytes and spermThe spermatozoa will be prepared in the standard fashion and utilized for injection after exposure to a membrane permeabilizing agent. Patient specimen will be selected through a synthetic, sterile, single-use, culture-tested mesh. The specimen will then be placed in a 37°C environment. After 30 minutes, the selected portion is retrieved from the other side of the mesh. The injected oocytes will be then exposed to the previously mentioned activating agents for the purpose of inducing embryo development. The successfully fertilized oocytes will be further kept in culture for up to 5 days as per standard IVF/ICSI.
Primary Outcome Measure
Fertilization rate [ Time Frame: 2 months ]
Central Contacts
- Rodriq Stubbs, NP646-962-3276
- Iman Mohammed, MPH646-962-3274
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Center fo Reproductive Medicine | New York | New York | 10021 | Gianpiero Palermo, MD, PhD (PRINCIPAL_INVESTIGATOR) |
Find similar trials in New York, NY
By research site
Related Studies
- Use of Artificial Intelligence for Clinical Assessment of Assisted Reproductive Techniques and IVF OutcomesRecruiting · Weill Medical College of Cornell University · New York, New York
- Sex Selection of Human SpermatozoaRecruiting · Weill Medical College of Cornell University · New York, New York
- Ovarian PRP Injections for Improved Embryo Quality Using Embryo Quality ScoreRecruiting · Generation Next Fertility · New York, New York
- Study to Create Potential Cell-Based Therapies to Treat Human Disease and DisabilityEnrolling By Invitation · Stanford University · Stanford, California